부산대학교 도서관

Rohwer, N; Jumpertz, S; Erdem, M; Egners, A; Warzecha, KT; Fragoulis, A; Kuhl, AA; Kramann, R; Neuss, S; Rudolph, I; Endermann, T; Zasada, C; Apostolova, I; Gerling, M; Kempa, S; Hughes, R; Lewis, CE; Brenner, W; Malinowski, MB; Stockmann, M; Schomburg, L; Faller, W; Sansom, OJ; Tacke, F; Morkel, M; Cramer, T

Oncogene. 38(28):5670-5685

Zasada, AA; Gierczynski, R; Raddadi, N; Daffonchio, D; Jagielski, M

JOURNAL OF CLINICAL MICROBIOLOGY; APR 2006, 44 4, p1606-p1607, 2p.

Prygiel M; Department of Sera and Vaccines Evaluation, National Institute of Public Health NIH-National Research Institute, Chocimska 24, 00-791 Warsaw, Poland.; Mosiej E; Department of Sera and Vaccines Evaluation, National Institute of Public Health NIH-National Research Institute, Chocimska 24, 00-791 Warsaw, Poland.; Polak M; Department of Sera and Vaccines Evaluation, National Institute of Public Health NIH-National Research Institute, Chocimska 24, 00-791 Warsaw, Poland.; Krysztopa-Grzybowska K; Department of Sera and Vaccines Evaluation, National Institute of Public Health NIH-National Research Institute, Chocimska 24, 00-791 Warsaw, Poland.; Wdowiak K; Department of Sera and Vaccines Evaluation, National Institute of Public Health NIH-National Research Institute, Chocimska 24, 00-791 Warsaw, Poland.; Formińska K; Department of Sera and Vaccines Evaluation, National Institute of Public Health NIH-National Research Institute, Chocimska 24, 00-791 Warsaw, Poland.; Zasada AA; Department of Sera and Vaccines Evaluation, National Institute of Public Health NIH-National Research Institute, Chocimska 24, 00-791 Warsaw, Poland.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101530765 Publication Model: Electronic Cited Medium: Internet ISSN: 2072-6651 (Electronic) Linking ISSN: 20726651 NLM ISO Abbreviation: Toxins (Basel) Subsets: MEDLINE

Krysztopa-Grzybowska K; Department of Sera and Vaccines Evaluation, National Institute of Public Health NIH - National Research Institute, Warsaw, Poland.; Lach J; Biobank Lab, Department of Oncobiology and Epigenetics, Faculty of Biology and Environmental Protection, University of Lodz, Lodz, Poland.; Polak M; Department of Sera and Vaccines Evaluation, National Institute of Public Health NIH - National Research Institute, Warsaw, Poland.; Strapagiel D; Biobank Lab, Department of Oncobiology and Epigenetics, Faculty of Biology and Environmental Protection, University of Lodz, Lodz, Poland.; Dziadek J; Mycobacterium Genetics and Physiology Unit, Institute of Medical Biology, Polish Academy of Sciences, Lodz, Poland.; Olszewski M; Chair of Drug and Cosmetics Biotechnology, Faculty of Chemistry, Warsaw University of Technology, Warsaw, Poland.; Zasada AA; Department of Sera and Vaccines Evaluation, National Institute of Public Health NIH - National Research Institute, Warsaw, Poland.; Darlińska A; Department of Sera and Vaccines Evaluation, National Institute of Public Health NIH - National Research Institute, Warsaw, Poland.; Lutyńska A; Department of Medical Biology, National Institute of Cardiology, Warsaw, Poland.; Augustynowicz-Kopeć E; Department of Microbiology, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland.

Publisher: ASM Press Country of Publication: United States NLM ID: 101634614 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2165-0497 (Electronic) Linking ISSN: 21650497 NLM ISO Abbreviation: Microbiol Spectr Subsets: MEDLINE

Garofalo M; Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy.; Wieczorek M; Department of Virology, National Institute of Public Health, National Institute of Hygiene (NIH) - National Research Institute, Warsaw, Poland.; Anders I; Division of Biomedical Research, Medical University of Graz, Graz, Austria.; Staniszewska M; Centre for Advanced Materials and Technologies, Warsaw University of Technology, Warsaw, Poland.; Lazniewski M; Centre for Advanced Materials and Technologies, Warsaw University of Technology, Warsaw, Poland.; Department of Bacteriology and Biocontamination Control, National Institute of Public Health, National Institute of Hygiene (NIH) - National Research Institute, Warsaw, Poland.; Prygiel M; Departament of Sera and Vaccines Evaluation, National Institute of Public Health, National Institute of Hygiene (NIH) - National Research Institute, Warsaw, Poland.; Zasada AA; Departament of Sera and Vaccines Evaluation, National Institute of Public Health, National Institute of Hygiene (NIH) - National Research Institute, Warsaw, Poland.; Szczepińska T; Centre for Advanced Materials and Technologies, Warsaw University of Technology, Warsaw, Poland.; Plewczynski D; Laboratory of Bioinformatics and Computational Genomics, Faculty of Mathematics and Information Science, Warsaw University of Technology, Warsaw, Poland.; Laboratory of Functional and Structural Genomics, Centre of New Technologies, University of Warsaw, Warsaw, Poland.; Salmaso S; Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy.; Caliceti P; Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy.; Cerullo V; Drug Research Program (DRP), ImmunoViroTherapy Lab (IVT), Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.; Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.; Translational Immunology Program (TRIMM), Faculty of Medicine Helsinki University, University of Helsinki, Helsinki, Finland.; Digital Precision Cancer Medicine Flagship (iCAN), University of Helsinki, Helsinki, Finland.; Department of Molecular Medicine and Medical Biotechnology and CEINGE, Naples University Federico II, Naples, Italy.; Alemany R; Oncobell Program of Bellvitge Biomedical Research Institute (IDIBELL), ProCure Program of Catalan Institute of Oncology (ICO), Avinguda de la Granvia de l'Hospitalet, L'Hospitalet de Llobrega, Barcelona, Spain.; Rinner B; Division of Biomedical Research, Medical University of Graz, Graz, Austria.; Pancer K; Department of Virology, National Institute of Public Health, National Institute of Hygiene (NIH) - National Research Institute, Warsaw, Poland.; Kuryk L; Department of Virology, National Institute of Public Health, National Institute of Hygiene (NIH) - National Research Institute, Warsaw, Poland.; Centre for Advanced Materials and Technologies, Warsaw University of Technology, Warsaw, Poland.; Clinical Science, Valo Therapeutics, Helsinki, Finland.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Zasada AA; Department of Sera and Vaccines Evaluation, National Institute of Public Health NIH-National Research Institute, 00-791 Warsaw, Poland.; Darlińska A; Department of Sera and Vaccines Evaluation, National Institute of Public Health NIH-National Research Institute, 00-791 Warsaw, Poland.; Wiatrzyk A; Department of Sera and Vaccines Evaluation, National Institute of Public Health NIH-National Research Institute, 00-791 Warsaw, Poland.; Woźnica K; Department of Sera and Vaccines Evaluation, National Institute of Public Health NIH-National Research Institute, 00-791 Warsaw, Poland.; Formińska K; Department of Sera and Vaccines Evaluation, National Institute of Public Health NIH-National Research Institute, 00-791 Warsaw, Poland.; Czajka U; Department of Sera and Vaccines Evaluation, National Institute of Public Health NIH-National Research Institute, 00-791 Warsaw, Poland.; Główka M; Department of Sera and Vaccines Evaluation, National Institute of Public Health NIH-National Research Institute, 00-791 Warsaw, Poland.; Lis K; Department of Sera and Vaccines Evaluation, National Institute of Public Health NIH-National Research Institute, 00-791 Warsaw, Poland.; Górska P; Department of Sera and Vaccines Evaluation, National Institute of Public Health NIH-National Research Institute, 00-791 Warsaw, Poland.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915 (Electronic) Linking ISSN: 19994915 NLM ISO Abbreviation: Viruses Subsets: MEDLINE

Prygiel M; Department of Sera and Vaccines Evaluation, National Institute of Public Health NIH-National Research Institute, Chocimska 24, 00-791 Warsaw, Poland.; Mosiej E; Department of Sera and Vaccines Evaluation, National Institute of Public Health NIH-National Research Institute, Chocimska 24, 00-791 Warsaw, Poland.; Wdowiak K; Department of Sera and Vaccines Evaluation, National Institute of Public Health NIH-National Research Institute, Chocimska 24, 00-791 Warsaw, Poland.; Rabczenko D; Department-Center for Monitoring and Analyses of Population Health Status, National Institute of Public Health NIH-National Research Institute, Chocimska 24, 00-791 Warsaw, Poland.; Zasada AA; Department of Sera and Vaccines Evaluation, National Institute of Public Health NIH-National Research Institute, Chocimska 24, 00-791 Warsaw, Poland.

Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101691304 Publication Model: Electronic Cited Medium: Print ISSN: 2227-9059 (Print) Linking ISSN: 22279059 NLM ISO Abbreviation: Biomedicines Subsets: PubMed not MEDLINE

Rastawicki W; Department of Bacteriology and Biocontamination Control, National Institute of Public Health NIH-National Research Institute, 00-791 Warsaw, Poland.; Gierczyński R; Department of Bacteriology and Biocontamination Control, National Institute of Public Health NIH-National Research Institute, 00-791 Warsaw, Poland.; Zasada AA; Department of Sera and Vaccines Evaluation, National Institute of Public Health NIH-National Research Institute, 00-791 Warsaw, Poland.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915 (Electronic) Linking ISSN: 19994915 NLM ISO Abbreviation: Viruses Subsets: MEDLINE

Wołkowicz T; Department of Bacteriology and Biocontamination Control, National Institute of Public Health NIH-National Research Institute, 24 Chocimska Str., 00-791 Warsaw, Poland.; Zacharczuk K; Department of Bacteriology and Biocontamination Control, National Institute of Public Health NIH-National Research Institute, 24 Chocimska Str., 00-791 Warsaw, Poland.; Zasada AA; Department of Sera and Vaccines Evaluation, National Institute of Public Health NIH-National Research Institute, 24 Chocimska Str., 00-791 Warsaw, Poland.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

Prygiel M; Department of Sera and Vaccines Evaluation, National Institute of Public Health NIH, National Research Institute, 00-791 Warsaw, Poland.; Polak M; Department of Sera and Vaccines Evaluation, National Institute of Public Health NIH, National Research Institute, 00-791 Warsaw, Poland.; Mosiej E; Department of Sera and Vaccines Evaluation, National Institute of Public Health NIH, National Research Institute, 00-791 Warsaw, Poland.; Wdowiak K; Department of Sera and Vaccines Evaluation, National Institute of Public Health NIH, National Research Institute, 00-791 Warsaw, Poland.; Formińska K; Department of Sera and Vaccines Evaluation, National Institute of Public Health NIH, National Research Institute, 00-791 Warsaw, Poland.; Zasada AA; Department of Sera and Vaccines Evaluation, National Institute of Public Health NIH, National Research Institute, 00-791 Warsaw, Poland.

Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101596317 Publication Model: Electronic Cited Medium: Print ISSN: 2076-0817 (Print) Linking ISSN: 20760817 NLM ISO Abbreviation: Pathogens Subsets: PubMed not MEDLINE